ICL Group Ltd (ICL) slips on deep earnings miss analysis
ICL Group Ltd (ICL) slips after a Q3 miss, but the deeper story is mixed. Margins held, EBITDA rose, and guidance stayed intact, yet revenue fell short and soft agriculture demand, higher costs, and cautious analyst sentiment kept pressure on the stock.
ICL Group Ltd (ICL) reported a mixed Q3 2026 result, with EPS of $0.10 and revenue of $1.91B both below expectations, sending shares down 2.46%. The company still protected profitability with a 32.9% gross margin, $402M in adjusted EBITDA, and reaffirmed its 2026 EBITDA outlook, but weaker agriculture demand and higher input costs weighed on the top line.
ICL Group Ltd (ICL) reported Q3 2026 EPS of $0.10, below the $0.11 estimate, while revenue reached $1.91B against a $2.13B consensus. Shares slipped 2.46% to $4.555 in the Nov. 11 regular session, showing that stronger margins did not offset the top-line disappointment.
The ICL Group Ltd earnings analysis is a study in mixed signals. Adjusted EBITDA rose 1% year over year to $402M, gross margin reached 32.9%, and management reiterated its 2026 EBITDA outlook. However, revenue fell below the prior quarter, several agriculture markets remained soft, and higher energy, sulfur, freight, and currency costs continued to pressure the business.
Key Takeaways
EPS came in at $0.10 versus the $0.11 estimate, while revenue of $1.91B missed the $2.13B consensus.
Industrial Products led the portfolio, with sales up 18% year over year to $347M and EBITDA up nearly 50% to $100M.
Potash sales rose 4% to $469M, but EBITDA fell about 7% as energy, transportation, and currency costs offset higher prices.
Phosphate Solutions generated $589M of sales and $118M of EBITDA, including a 20% EBITDA margin despite higher sulfur costs.
ICL maintained 2026 adjusted EBITDA guidance of $1.5B to $1.7B and said it is targeting a result above the midpoint.
The analyst backdrop remained cautious. The consensus tracked four Hold ratings, while Morgan Stanley lowered its price target to $5.45 from $5.75 and kept an Equal Weight rating.
ICL Financial Performance: Revenue Miss, Margins Hold
ICL generated $1.91B of quarterly revenue, up 3% from the same period last year. The result still marked a step down from $2.13B in Q2 and $2.02B in Q1. Revenue exceeded the $1.70B recorded in Q4 2025 and the $1.85B reported in Q3 2025, but the sequential decline explains the market's focus on demand and volume.
The earnings profile was steadier than the sales figure. Adjusted net income rose 2% year over year to $126M, producing adjusted EPS of $0.10. EPS declined from $0.11 in Q2 but remained above the $0.0976 recorded in Q1. It also matched Q3 2025 EPS of $0.10 and improved sharply from the $0.0566 loss per share reported in Q4 2025.
Gross margin improved 30 basis points year over year to 32.9%, the highest level since Q4 2024. Adjusted EBITDA increased to $402M, even as ICL absorbed record raw material prices and elevated freight and logistics costs. The margin result shows that pricing and product mix actions helped defend profitability, although the revenue miss shows that those actions did not fully replace lost quantities.
Industrial Products was the clear standout. Sales reached $347M, supported by higher bromine prices, stronger electronics demand, better construction demand for phosphorus products, and stable specialty minerals demand. EBITDA reached $100M. Bromine prices increased nearly 40% year over year, and management said prices rebounded in October to first-quarter levels.
Potash delivered $469M of sales and $157M of EBITDA. Average potash pricing reached $370 CIF per ton, up 5% year over year but down 2% sequentially. A higher share of shipments went to India and China under annual contracts, where prices generally sit below spot levels. Production volume was 1.146M metric tons, in line with the prior year.
Phosphate Solutions produced $589M of sales and $118M of EBITDA, equal to a 20% EBITDA margin. Specialty food and industrial phosphates performed well, while phosphate fertilizer quantity and profitability declined. Sulfur prices averaged more than 220% above the prior year, creating a major cost burden. October sulfur prices fell 12% from the third-quarter average, and ICL expects lower purchase prices to benefit results in Q1 2027.
Growing Solutions reported $538M of sales and $44M of EBITDA. Brazil remained weak as customers delayed purchases and shifted toward less premium products. Europe also faced weaker demand tied to farmer affordability. North America was stable, while Asia delivered modest growth in sales and profit.
Cash generation was positive but less impressive than operating income. Operating cash flow reached $256M, while free cash flow was $66M. Inventory increased because of softer commodity phosphate demand and higher sulfur costs. Available cash resources stood at $2.2B, net debt to adjusted EBITDA remained 1.5x, and ICL paid a $63M dividend equal to 50% of adjusted net income.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
MarketBeat placed ICL shares around $4.68 on Nov. 10. By the next regular session, the stock traded at $4.555, down 2.46% at 14:30 ET. Volume stood at 1.257M shares versus an average of 1.488M, so the decline came without unusually heavy trading.
The reaction reflects a difficult balance. The company protected gross margin and kept its annual EBITDA target, but revenue missed by a wide margin relative to the $2.13B estimate. The result also included weaker quantities, soft demand in Brazil and Europe, and a 7% annual decline in Potash EBITDA.
Morgan Stanley provided the clearest fresh sell-side action. Analyst Vincent Andrews lowered the price target to $5.45 from $5.75 and retained an Equal Weight rating. The target reduction matters because it followed guidance reaffirmation. It signals concern about earnings quality, cost pressure, and the durability of margins rather than a direct challenge to the full-year EBITDA target.
The broader rating picture remained neutral. The tracked consensus showed four Hold ratings, with no Buy or Sell ratings. MarketBeat listed two Hold ratings and an average target of $6.00. Earlier positioning included Barclays maintaining Equal Weight while cutting its target to $6 from $7, while BMO Capital maintained Market Perform and raised its target to $6.50 from $6.
“Sharply lower margins/returns versus prior-cycle levels” and weaker cash conversion remain central concerns in the neutral analyst view. - TipRanks post-earnings summary
CEO Elad Aharonson framed the quarter as a resilience test. ICL raised prices in key markets, focused on higher-margin products, and held adjusted EBITDA above the prior year despite raw material and logistics inflation.
“Looking ahead, industry fundamentals remain constructive, supported by healthy global demand and continued supply and logistics constraints in key regions.” - Elad Aharonson, CEO, ICL earnings call
That view rests most clearly on Potash affordability, global food demand, and supply constraints. Yet the quarter also showed the limit of that argument. Potash prices increased, but EBITDA declined because destination mix, energy, transportation, and exchange rates absorbed the benefit.
“Our diverse portfolio of food, industrial and agriculture solutions provides offsets during times of seasonality and end market inconsistency.” - Elad Aharonson, CEO, ICL earnings call
The CEO's portfolio argument received support from Industrial Products. Higher bromine prices and improved electronics demand offset pressure in agriculture-related markets. However, Growing Solutions generated only $44M of EBITDA on $538M of sales, showing that diversification does not remove exposure to farmer affordability.
“We are reiterating our guidance and continue to expect consolidated EBITDA to be between $1.5B and $1.7B, and are currently targeting to be ahead of the midpoint of this range.” - Asaf Alperovitz, CFO, ICL earnings call
CFO Asaf Alperovitz's guidance is the most important numerical support for the stock. ICL kept its full-year target despite the revenue miss and cost inflation. The company also maintained its 4.5M to 4.7M metric ton Potash volume outlook.
“Lower purchase prices should begin to benefit our results in the first quarter of next year.” - Asaf Alperovitz, CFO, ICL earnings call
That comment ties the near-term outlook to sulfur rather than to a broad demand rebound. October sulfur prices fell 12% from the third-quarter average, but the normal lag between purchase and consumption pushes the financial benefit into 2027. Freight rates remained elevated, with bulk carrier prices up 24% year over year and 9% sequentially.
Bottom Line
ICL delivered margin resilience and reaffirmed its 2026 EBITDA target, but the revenue miss and weaker Potash and Growing Solutions trends keep the stock in a neutral camp. The investment case improves if sulfur costs ease as stated and Industrial Products remains strong, while the $4.555 share price still reflects skepticism about demand, cash conversion, and earnings durability.
ICL Group Ltd (ICL) fell after reporting Q3 2026 EPS of $0.10 versus the $0.11 estimate and revenue of $1.91B versus the $2.13B consensus. Investors focused on the large revenue miss and softer demand, even though gross margin improved to 32.9% and adjusted EBITDA rose to $402M.
+Did ICL Group beat earnings in Q3 2026?
No. ICL reported adjusted EPS of $0.10, which was below the $0.11 analyst estimate, while revenue also missed expectations at $1.91B versus $2.13B. The company did, however, post a 1% year-over-year increase in adjusted EBITDA to $402M.
+What is ICL Group's 2026 EBITDA guidance after the quarter?
ICL maintained its 2026 adjusted EBITDA guidance at $1.5B to $1.7B and said it is targeting a result above the midpoint. Management said stronger margins and portfolio performance support that outlook despite softer agriculture markets and higher costs.
+Which ICL business segments performed best in Q3 2026?
Industrial Products was the standout, with sales up 18% year over year to $347M and EBITDA up nearly 50% to $100M. Phosphate Solutions also held up well with $589M of sales and $118M of EBITDA, while Potash saw EBITDA decline about 7% as costs offset higher prices.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on ICL?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
